Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

Blood Loss Massive clinical trials

A small indexed set (2 trials) with no open enrollment listed right now.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count

Blood Loss Massive: 2 US clinical trials tracked, none currently recruiting.

Blood Loss Massive is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is HemoSonics, running 2 of these trials.

Enrollment posture brief

Registry condition blood-loss-massive

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #7188 | SPON 2

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Blood Loss Massive (this)0%
Open-enrollment share among volume-matched conditions near Blood Loss Massive

Blood Loss Massive has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Blood Loss Massive on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Blood Loss Massive is recruiting below its size-band peers.

    0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

HemoSonics 2 trials

Named interventions

Most-linked intervention names on Blood Loss Massive records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Quantra Hemostasis Analyzer with the QStat Cartridge Diagnostic test
1 trials
Quantra System Diagnostic test
1 trials

US sites by state

Facility locations filed on Blood Loss Massive trials. A trial with sites in several states counts in each.

Utah 1 trials
Texas 1 trials
Pennsylvania 1 trials
Oklahoma 1 trials
Ohio 1 trials
New York 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Blood Loss Massive page

2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Blood Loss Massive trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • HemoSonics sponsors the most Blood Loss Massive trials on record, review their full trial history before evaluating a specific study. See HemoSonics's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Blood Loss Massive condition card totals 2 registered trials; most-linked intervention Quantra Hemostasis Analyzer with the QStat Cartridge; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.